<?xml version="1.0" encoding="UTF-8"?>
<p id="par0045">Transfusion services and many other establishments with the appropriate skills in handling therapeutic apheresis have the appropriate know how to effectively perform this process. Therefore, a protocol that is based on local community testing, which is becoming an essential part of the current strategy is warranted. As highlighted before this will be of benefit to both recipients and donors. There is, moreover another, validated strategic safety measure that could be implemented for the quality improvement of plasmapheresis FFP and its derived cryo supernatant, based on pathogen reduction with UVC. This has been validated and uses the principle of sterilization to kill both viruses and bacteria.</p>
